Bioelectronic medicine, reimagined

A new signal of hope for PTSD.

Evren is developing non-invasive bioelectronic devices that use vagus nerve stimulation to help people rise above post-traumatic stress disorder.

Investigational device
Built for clinical research
Scroll to discover
NON-INVASIVEPERSONALIZEDPORTABLERESEARCH-READY
01 — The need

PTSD changes lives.
Treatment should too.

PTSD can disrupt sleep, relationships and everyday life. Millions still seek effective relief—creating an urgent need for new approaches beyond traditional drugs and therapy.

Treatment market$18B

Estimated PTSD treatment market

Annual impact13M

Americans experience PTSD each year

Unmet need66%

Are still seeking relief

LONG BATTERY LIFEREAL-TIME MONITORINGFULLY PROGRAMMABLEPhoenix CR taVNS research device
02 — The Phoenix CR

Research without compromise.

The Phoenix® CR is designed specifically to produce high-quality transcutaneous auricular vagus nerve stimulation data from human clinical trials.

  • Soft, conforming earpiece in three sizes
  • Minimal interruption to daily life
  • Protocol control and adherence tracking
For researchers

Fully programmable

Time, intensity, sham and calibration control.

Live impedance

Real-time monitoring for protocol-defined stimulation.

Built for daily life

Hands-free sessions and long battery life.

Research-ready data

Track adherence and download study data.

03 — How it works

A small signal.
A powerful pathway.

The vagus nerve helps regulate the body’s “fight or flight” and “rest and relax” responses. taVNS delivers mild electrical stimulation through the ear.

01

Gentle stimulation

The earpiece delivers light electrical pulses.

02

Vagus activation

Signals travel along the auricular vagal pathway.

03

Restoring balance

Research explores autonomic balance and neuroplasticity.

taVNS research areas
Traumatic Brain InjuryPTSDAnxietyDepressionSleep DisruptionCognition & LearningTinnitusAdjustment Disorders
04 — Patient story

Meet Andy.
Hear his story.

Andy shares how living with PTSD affected his everyday life and his experience with Evren's investigational bioelectronic technology.

The Evren Phoenix has not been approved by FDA, and its safety and effectiveness have not yet been established.

05 — Pilot study

Promising results.
Real voices.

Patients in Evren’s pilot study were among the first to experience the Phoenix®. The investigational study reported clinically and statistically significant results.

18.4
point average reductionin CAPS-5 score

Pilot study p-value: .0100, 95% CI: 0.57–0.98.

My wife says she has her husband back and our kids have their dad back.
AndyPilot study participant
06 — About Evren

Stimulating change,
together.

Evren Technologies is a bioelectronic medical device company and innovator in neuromodulation technologies.

Our mission is to empower patients to rise above PTSD and improve their lives through non-invasive, portable neuromodulation products.

07 — Our vision

Help shape the future of PTSD treatment.

Evren is looking for investors to help fund the final stages of FDA clinical trials and go-to-market activities for the Phoenix CR system.

Get investor information
PTSD resources

Looking for help right now?

We’ve curated trusted information and support resources for people living with PTSD and those who care for them.

Explore resources